An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify

Hisakazu Nishimori, Shunji Takahashi, Eijiro Nagasaki, Takayuki Kobayashi, Masahiro Yokoyama, Eiji Shinozaki, Yuko Mishima, Yasuhito Terui, Keisyo Chin, Nobuyuki Mizunuma, Yoshinori Ito, Kentaro Inamura, Kiyohiko Hatake

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.

Original languageEnglish
Pages (from-to)671-673
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume32
Issue number5
Publication statusPublished - May 2005
Externally publishedYes

Fingerprint

Islets of Langerhans
Carcinoma
Drug Therapy
Carboplatin
docetaxel
Ameloblastoma
Neuroendocrine Carcinoma
Cheek
Paclitaxel
Cisplatin
Area Under Curve
Pancreas
Autopsy
Neck
Head
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Nishimori, H., Takahashi, S., Nagasaki, E., Kobayashi, T., Yokoyama, M., Shinozaki, E., ... Hatake, K. (2005). An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify. Gan to kagaku ryoho. Cancer & chemotherapy, 32(5), 671-673.

An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify. / Nishimori, Hisakazu; Takahashi, Shunji; Nagasaki, Eijiro; Kobayashi, Takayuki; Yokoyama, Masahiro; Shinozaki, Eiji; Mishima, Yuko; Terui, Yasuhito; Chin, Keisyo; Mizunuma, Nobuyuki; Ito, Yoshinori; Inamura, Kentaro; Hatake, Kiyohiko.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 32, No. 5, 05.2005, p. 671-673.

Research output: Contribution to journalArticle

Nishimori, H, Takahashi, S, Nagasaki, E, Kobayashi, T, Yokoyama, M, Shinozaki, E, Mishima, Y, Terui, Y, Chin, K, Mizunuma, N, Ito, Y, Inamura, K & Hatake, K 2005, 'An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 32, no. 5, pp. 671-673.
Nishimori, Hisakazu ; Takahashi, Shunji ; Nagasaki, Eijiro ; Kobayashi, Takayuki ; Yokoyama, Masahiro ; Shinozaki, Eiji ; Mishima, Yuko ; Terui, Yasuhito ; Chin, Keisyo ; Mizunuma, Nobuyuki ; Ito, Yoshinori ; Inamura, Kentaro ; Hatake, Kiyohiko. / An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2005 ; Vol. 32, No. 5. pp. 671-673.
@article{9f2269562e154116af9e74dc9feba9b8,
title = "An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify",
abstract = "A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.",
author = "Hisakazu Nishimori and Shunji Takahashi and Eijiro Nagasaki and Takayuki Kobayashi and Masahiro Yokoyama and Eiji Shinozaki and Yuko Mishima and Yasuhito Terui and Keisyo Chin and Nobuyuki Mizunuma and Yoshinori Ito and Kentaro Inamura and Kiyohiko Hatake",
year = "2005",
month = "5",
language = "English",
volume = "32",
pages = "671--673",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify

AU - Nishimori, Hisakazu

AU - Takahashi, Shunji

AU - Nagasaki, Eijiro

AU - Kobayashi, Takayuki

AU - Yokoyama, Masahiro

AU - Shinozaki, Eiji

AU - Mishima, Yuko

AU - Terui, Yasuhito

AU - Chin, Keisyo

AU - Mizunuma, Nobuyuki

AU - Ito, Yoshinori

AU - Inamura, Kentaro

AU - Hatake, Kiyohiko

PY - 2005/5

Y1 - 2005/5

N2 - A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.

AB - A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.

UR - http://www.scopus.com/inward/record.url?scp=19544374527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544374527&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 671

EP - 673

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 5

ER -